Management

M. Sue Preston, President and Chief Executive Officer, joined Arriva in 2004 as Vice President of Regulatory and Quality, taking responsibility for the development of the company’s global regulatory and quality activities. Ms. Preston has more than 20 years of experience in implementing novel regulatory and quality strategies for timely product approvals. Prior to joining Arriva, Ms. Preston held senior management positions at Chiron Corporation, Alpha Therapeutic Corporation, and Baxter Healthcare, and also spent 14 years at the National Institutes of Health and US Food and Drug Administration. She received her BA from Lycoming College and did graduate work in biochemistry and physiology at the University of Maryland.